DGEFX
Price
$13.86
Change
+$0.01 (+0.07%)
Updated
Jul 25 closing price
Net Assets
473.58M
EPSRX
Price
$24.23
Change
+$0.06 (+0.25%)
Updated
Jul 25 closing price
Net Assets
802.77M
Interact to see
Advertisement

DGEFX vs EPSRX

Header iconDGEFX vs EPSRX Comparison
Open Charts DGEFX vs EPSRXBanner chart's image
Destinations Equity Income I
Price$13.86
Change+$0.01 (+0.07%)
VolumeN/A
Net Assets473.58M
NYLI Epoch Global Equity Yield Class R6
Price$24.23
Change+$0.06 (+0.25%)
VolumeN/A
Net Assets802.77M
DGEFX vs EPSRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DGEFX vs. EPSRX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEFX is a Buy and EPSRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
EPSRX has more cash in the bank: 803M vs. DGEFX (474M). DGEFX pays higher dividends than EPSRX: DGEFX (2.44) vs EPSRX (2.23). DGEFX was incepted earlier than EPSRX: DGEFX (8 years) vs EPSRX (12 years). DGEFX (1.07) is less costly to investors than EPSRX (0.75). DGEFX is a more actively managed with annual turnover of: 45.00 vs. EPSRX (18.00). DGEFX (0) and EPSRX (0) have matching initial minimum investment requirements. DGEFX annual gain was more profitable for investors over the last year : 16.14 vs. EPSRX (9.57). DGEFX (73.93) and EPSRX (70.40) have equivalent 5 years return.
DGEFXEPSRXDGEFX / EPSRX
Total Expense Ratio0.940.74127%
Annual Report Gross Expense Ratio1.070.75143%
Fund Existence8 years12 years-
Gain YTD11.83714.04984%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets474M803M59%
Annual Yield % from dividends2.442.23110%
Returns for 1 year16.149.57169%
Returns for 3 years35.1443.3581%
Returns for 5 years73.9370.40105%
Returns for 10 yearsN/A51.35-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO9.610.45
+4.91%
Alvotech
MRKR1.560.06
+4.00%
Marker Therapeutics
BLFS22.580.32
+1.44%
BioLife Solutions
ACU43.28-0.13
-0.30%
Acme United Corp
IX23.09-0.09
-0.39%
Orix Corp